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Background. Postoperative adhesions remain a major clinical problem after abdominal surgery. We
evaluated the efficacy of a new poly(trimethylene carbonate) (PTMC) film as an antiadhesive material.
In many abdominal operations, there is an increased risk of fecal contamination; the risk of (increased)
infection in presence of PTMC film was studied in 2 additional animal models.
Methods. A validated rat adhesion model with peritoneal ischemic buttons was used to compare the new
PTMC film with a hyaluronate carboxymethylcellulose (HA-CMC) sheet, icodextrin solution, and a
control group. Primary endpoint was occurrence of adhesions at the ischemic buttons after 14 days in 44
rats (n = 11 per group). To evaluate potential risks associated with the film, both an anastomotic leakage
model and a cecal ligation and puncture model were used. Kruskal–Wallis tests with subsequent Mann–
Whitney tests were used to detect differences between groups.
Results. PTMC film showed a significant reduction in the amount of adhesions (median, 0.5 buttons)
comparedwith control group (median, 4 buttons;P<.001) and icodextrin group (median, 4.5;P<.001).
The amount of adhesions was similar to the HA-CMC group (median, 2; P = .04). The presence of the film
did not increase the risk of anastomotic leakage or bacterial growth in a contaminated environment.
Conclusion. The presence of aPTMCfilm leads to a significant reduction in the amount of adhesions after 14
days in an ischemic button ratmodel. Furthermore, this filmwas found to be safe in an animalmodel, even in
complex abdominal operations with an increased risk of fecal contamination. (Surgery 2015;157:1113-20.)From the Department of General Surgery,a and the NUTRIM School for Nutrition, Toxicology and Metabo-
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1114 Vogels et alwithin the first 10 years.2-4 Unfortunately, the
appearance of adhesion formation remains as an
underestimated clinical problem.5-7 Many different
materials have been developed for the prevention
of postoperative adhesions.8-10 Of these materials,
mainly the ‘‘barrier-type’’ materials, like hyaluro-
nate carboxymethylcellulose (HA-CMC; Seprafilm,
Genzyme Biosurgery, Sanofi, The Netherlands)
have been found to be effective in reducing the
amount of severe adhesions.8,11,12 Results of
‘‘liquid-based’’ adhesion prevention, such as intra-
peritoneal administration of icodextrin (Adept),
are still inconclusive.10,12,13
Barrier materials are believed to work by
providing an inert and inactive barrier between
tissues to reduce adhesion formation without
providing bioactive properties, allowing the peri-
toneum to heal, while inducing minimal foreign
body reaction.14,15 Although these materials show
a significant reduction in the number of adhe-
sions, we believe these results can be improved by
using a more stable barrier material. This could
be achieved by using poly(trimethylene carbonate)
(PTMC), an inert, slow degrading polymer with
excellent biocompatibility.16 In addition, it was
shown that the polymer is phagocytized by macro-
phages and that at 12 weeks PTMC is degraded,
whereas only a small area of inflammatory cells
could be observed at the site of implantation.16,17
Unlike other materials that can be used to produce
membrane, such as collagen, this polymer de-
grades through surface degradation, allowing it
to retain its mechanical characteristics throughout
the degradation process.16-18 Furthermore, in
bone regeneration studies, PTMC promoted
bone healing without leading to osseous deposi-
tions inside the film owing to solid composition,
in contrast with collagenous membranes.17 This
led to the hypothesis that PTMC could provide
an adequate barrier against postoperative adhe-
sions when placed intraperitoneally.
To evaluate the efficacy of PTMC film (Flex-
isurge Adhesion Barrier, Medisse BV, Ede, The
Netherlands) as an antiadhesive material, we
compared this material with 2 commercially avail-
able antiadhesive therapies (Seprafilm and Adept),
and a control group in a rat adhesion model. We
hypothesize that the PTMC film provides adequate
adhesion prevention, at least comparable with that
of commercially available therapies.
Because abdominal surgery involves resection of
parts of the bowel, it should be investigated if theuse
of the PTMC film is safe in the presence of
gastrointestinal anastomoses. The concept that an
equilibrium exists between collagen synthesis andlysis, which can result in either adhesion formation
or anastomotic leakage, is widely accepted.19
Furthermore, the presence of a foreign body, persis-
tent infection, or trauma can cause adhesions.20
Therefore, it was crucial to examine whether the
PTMC film would still be effective in an infected
milieu, without aggravating the infection. In this
study, we investigated potential risks associated
with the use of the PTMC film both in the presence
of a colonic anastomosis and in the case of polymi-
crobial sepsis in an experimental rat model.
MATERIALS AND METHODS
Materials. PTMC was polymerized by ring open-
ing polymerization of 1,3-trimethylene carbonate
(For You Medical, P.R. China). Subsequently, the
PTMC polymer was compression molded into
films. Films produced had an average thickness
of 150 mm. Sterilization was performed under inert
atmosphere using gamma radiation. An A-B-A
PTMC–polyethylene glycol (PEG)–PTMC triblock
copolymer was synthesized by ring opening poly-
merization of 1,3-trimethylene carbonate using
PEG (Sigma Aldrich, St Louis, MO) as initiator.
Commercially available products of HA-CMC
(Seprafilm) and icodextrin 4% (Adept Adhesion
Reduction Solution, Baxter, Utrecht, The
Netherlands) were purchased and used according
to the manufacturer’s instructions. Before surgery,
HA-CMC sheets were cut into 5 3 7-cm patches
under sterile conditions. The experimental PTMC
sheets were provided as individually packed sterile
films measuring 9 3 6 cm and were cut to a size of
5 3 7 cm before operation.
Animals. Ninety adult male Wistar rats (Harlan,
Horst, The Netherlands) with a body weight of
200–250 g were housed at the Central Animal
Facilities of the Maastricht University. Male rats
were chosen because their anatomy allows scrotal
fat to form adhesions quite easily. Furthermore,
studies have showed that female hormones can
affect adhesion formation.21,22 Animals were cared
for according to local standards and were provided
with free access to food and water. The experi-
mental protocol complied with the Dutch Animal
Experimental Act and was approved by the Ethical
Committee of Animal Experiments.
Study design. The experiment was divided into
3 parts. In the first part, the efficacy of the PTMC
film was compared with commercially available
antiadhesion products (n = 44; n = 11 per group)
with a follow-up of 14 days:
 Group 1 was implanted with the PTMC film. This film
was fixed intraperitoneally with the tacky copolymer
Fig 1. Three ischemic buttons were created on each side
of the abdominal wall.
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migration of the film; additional fixation of the cor-
ners to the abdominal wall using 4 polyglactin 4-0 su-
tures was applied.
 Group 2 had the HA-CMC film implanted intraperito-
neally. Application of the film was done according to
the manufacturer’s instructions.
 Group 3 received an intraperitoneal dose of 5 mL ico-
dextrin 4%, which corresponds with 1.5 L in an adult
male subject weighing 75 kg.
 Group 4 had no material implanted and was consid-
ered the control group.
In the second part, the effect of the PTMC film
on a colonic anastomosis was investigated (n = 26;
n = 13 per group), and in the third part a cecal liga-
tion and puncture model was used to compare
infection rate between the PTMC group and a con-
trol group (n = 20; n = 10 per group). Follow-up
was 7 days in both high-risk studies.
Operative procedure efficacy study. Before
surgery, all animals received a subcutaneous injec-
tion of 0.05 mg/kg buprenorphine. Anesthesia was
induced with isoflurane 5% and maintained with
isoflurane 2.5%. The abdomen was shaved and
disinfected, and the animals were placed in the
supine position. A 5- to 6-cm midline incision was
performed, through which the abdomen was
accessed. Ischemic buttons were created according
to the technique described by Rajab et al.23 In
short, musculoperitoneal tissue was lifted using
surgical forceps after which a suture was run
through the base of the button. A ligature was
made on 1 side of the button, followed by a similar
ligature around the complete base of the button.
Using this technique, 6 buttons were created in
each animal, 3 on each side of the midline. The
buttons had a diameter of approximately 0.5 cm,
and were spaced 1 cm apart (Fig 1).23,24 Subse-
quently, a 1 3 1-cm portion of the tip of the cecum
was abraded using a sterile cotton swab until pete-
chial lesions occurred.25,26 After humane killing
with an inhalation overdose of carbon dioxide,
the abdomen was opened through an H-shaped
incision along the old midline incision, and toward
the flanks caudal and cranial of the ischemic but-
tons. Care was taken to avoid dissection through
the ischemic buttons or through existing adhe-
sions. The amount of adhesions to the ischemic
buttons, midline, cecum, or sutures was scored
macroscopically.
Operative procedure safety study. A rat model
for colonic anastomosis was used in which the
abdominal cavity was accessed through a 5-cm
craniocaudal midline incision of the skin andabdominal musculature. The cecum was identified
and placed on sterile gauzes hydrated with sterile
saline solution to prevent dehydration. The colon
was transected 2 cm distal from the cecum and an
end-to-end anastomosis was created using 12
interrupted polypropylene 6/0 sutures (Prolene,
Ethicon, Johnson & Johnson, Somerville, NJ; Fig 2,
A), after which the intestines were repositioned
into the abdominal cavity and the PTMC film
was implanted and fixed to the abdominal wall.
To induce a controlled infection cecal ligation
and puncture was performed as described previ-
ously.27,28 In this model, the cecum was manipu-
lated carefully outside the abdominal cavity and
ligated just distal to the ileocecal valve with a
monofilament nonabsorbable suture (4/0 Ethilon;
Ethicon, Johnson & Johnson), maintaining the
continuity of the bowel. The cecum was punctured
distally to the ligation with an 18-G needle. No
PTMC film was implanted during the initial opera-
tion. After 1 day, animals underwent relaparotomy
to assess the extent of infection using peritoneal
swabs and place a PTMC film in animals in the
PTMC group.
For means of hydration a bolus of 2 mL of
sterile saline solution was injected subcutaneously.
In all experiments, the abdominal wall was closed
using an absorbable running suture of polyglactin
4-0 (Vicryl; Ethicon, Johnson & Johnson). The skin
was closed intracutaneously with a running suture
of polyglecaprone 4-0 (Monocryl; Ethicon, John-
son & Johnson).
Adhesion scoring. Adhesions to buttons were
scored by 2 independent observers. The number
of buttons with adhesions present was recorded.
Data were presented as mean number of buttons
with adhesions. Adhesions to the abraded cecum
and midline were recorded in a similar fashion.
Fig 2. Safety of PTMC in the abdominal cavity was investigated using an anastomotic leakage model (A) and a cecal
ligation and puncture model (B).
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motic leakage was graded on a scale from 0 (no
anastomotic leakage), 1 (small abscess at the
anastomotic site < 1 cm3), 2 (large [>1 cm3] ab-
scess at the anastomotic site), 3 (fecal pollution
of the abdomen), to 4 (complete dehiscence with
peritonitis). Adhesions at the anastomotic site
were evaluated in a blinded fashion according to
the scoring scale of van der Ham et al.29
After humane killing, the anastomotic segment
was resected and paraffin-embedded sections were
prepared. Sections were stained with hematoxylin
and eosin using standard histologic techniques.
Specimens were randomly scored according to the
0–4 Ehrlich and Hunt numerical scale as modified
by Phillips et al.30
Bursting pressure. A 5-cm segment of intestine
including the anastomosis with and adherent
organs was resected en bloc. The colon distal of
the anastomosis was clamped, and a plastic tube
was inserted in the proximal end and ligated with a
single polyglactine 4/0 suture (Vicryl, Ethicon).
Each anastomosis was immersed in 13 phosphate-
buffered saline, air was infused using a pressure
device attached to a manometer (IDEE, Maastricht
University, Maastricht, The Netherlands) and pres-
sure was manually increased by inflating the colon
with air. The bursting pressure of the anastomosis
was defined as the intraluminal pressure at which
air leakage was initially observed from the anasto-
mosis (mBar).
Infection rate. At day 1, 1 day after the cecal
ligation and puncture, the abdomen was reopened
through the midline incision, and a culture swab
of the abdominal cavity was obtained to confirmfecal peritonitis. At day 7, animals were humanely
killed and culture swabs were taken to measure
infection. Swabs were analyzed using broad-range
16S ribosomal RNA gene polymerase chain reac-
tion for detection and identification of bacterial
pathogens. Furthermore, plasma was collected
with a cardiac puncture to perform a blood culture
to check for sepsis.
Statistical analysis. All data concerning adhe-
sions are expressed as median with range.
Normality tests using the Kolmogorov–Smirnov
test were performed. Nonparametric data were
analyzed using the Kruskal–Wallis test. In case of
significance, the difference was confirmed by the
Mann–Whitney test, followed by a Bonferroni post
hoc test. For categorical data, a Fisher’s exact test
was performed. Statistical analyses were performed
using Prism 5.0 for Mac (Graphpad Software, Inc,
San Diego, CA) and SPSS 20.0 for Mac (SPSS Inc,
Chicago, IL).RESULTS
Two animals died during follow-up in the
efficacy study. One animal from group 3 died
preoperatively, possibly owing to an overdose of
anesthetic. Another animal from group 1 died 5
days after the initial operation; this was owing to
severe sepsis caused by leakage of bowel content
through a cecal perforation. All other animals
showed a normal postoperative recovery. In the
safety studies, all animals completed the 7-day
follow-up. Welfare of animals in both the efficacy
and safety studies was assessed using extensive
scoring, but no humane endpoints were reached
Fig 3. Number of buttons with adhesions per group.
Data are presented as median values ± interquartile
range. *P < .008. PTMC, Poly(trimethylene carbonate).
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tion and control groups.
Macroscopic evaluation. The PTMC films
showed no signs of degradation after 14 days and
could be explanted at killing. The film was still in
situ in all of the surviving animals. Contrary to
PTMC, the icodextrin and HA-CMC were
completely resorbed after 14 days. None of the
surviving animals in the efficacy study showed
macroscopic signs of infection or severe inflamma-
tory reaction. In the safety studies, signs of inflam-
mation and discomfort were found, but were
equivalent in the PTMC and control groups.
The use of a PTMC film reduces adhesion
formation. PTMC films had the lowest number of
adhesions to ischemic buttons of all studied groups
with a median of 0.5 (range, 0–3) buttons per
animal. This difference was significant compared
with the control group (median, 4; range, 2–6)
and the icodextrin group (median, 4.5; range, 0–6;
P < .001), but not to the HA-CMC implant group
(median 2; range, 0–5; P = .04). Results of adhe-
sion formation to the ischemic buttons are pre-
sented in Fig 3 and Supplementary Fig 1.
Adhesions in the PTMC and HA-CMC groups
seemed to be mostly filmy and of omental and
scrotal fat origin. None of these adhesions
required aggressive or sharp dissection. No adhe-
sions of visceral organs to the buttons were found
in these groups. In contrast, the control and
icodextrin groups showed more pronounced
dense adhesions. These adhesions required more
aggressive blunt and sharp dissection. Adhesions
of liver, cecum, and small intestine to the ischemic
buttons were recorded in addition to the usual
fatty adhesions in these groups.
The use of sutures to fix the PTMC to the
abdominal wall, however, seems to increase the riskof undesirable adhesions to these sutures.
Although the film seems to protect the ischemic
buttons from adhesions forming to these buttons,
the sutures are not protected. All 11 animals in the
PTMC group had adhesions present attached to
sutures fixing the film. These adhesions were
denser and more difficult to dissect than those to
the ischemic buttons in the same animals. Further-
more, most adhesions to ischemic buttons in this
group seemed to be closely related to adhesions
formed to these sutures.
No differences were found in the amount of
adhesions adhered to the abraded cecum. In all
but the PTMC group, 4 out of the total 11 animals
have some sort of adhesion toward the abraded
cecum. In the PTMC group only 2 animals showed
adhesions toward the cecum. No differences were
found between the groups using Fisher’s exact test
(Supplementary Fig 2, A).
Equal anastomotic leakage in both PTMC and
control group. We found no higher anastomotic
leakage rate in the PTMC group (3/13) compared
with the control group (4/13; P = 0.99;
Supplementary Fig 2,D); the severity of anastomotic
leakage did not differ between groups (P = .695;
Supplementary Fig 2, C). The anastomoses in the
PTMC group needed higher pressure to burst
(249 ± 14.2 vs 195 ± 22.0 mBar; Supplementary Fig
2, B; P = .067). Microscopically, no differences
were found between experimental groups.
No differences in infection rate between
experimental groups. Bacterial load at day 7 did
not differ between PTMC (3.13108 copies/mL; in-
terquartile range, 1.03106 9.831010) and control
groups (8.13108 copies/mL; interquartile range
2.13108  3.13109; P = .35; Supplementary Fig 2,
E). There were no differences in the frequency of
positive versus negative blood cultures between
groups (P = .637; Supplementary Fig 2, F).DISCUSSION
In this study, we investigated a new antiadhesive
barrier composed of PTMC (co)polymers and
compared it with commercially available antiadhe-
sive therapies. Prevention of intraperitoneal adhe-
sions remains an integral part of daily surgery
practice.6 Postoperative adhesions are known to
have a devastating impact on quality of life and in-
creases the risk for reoperations.31 Even though
the use of minimally invasive techniques seems to
reduce the risk of adhesion formation, this is not
sufficient to adequately prevent all postoperative
adhesions, indicating there is still need for addi-
tional adhesion prevention.1,15,32,33
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material with highly favorable characteristics.34,35
Contrary to currently available materials, the
PTMC film degrades by surface degradation, not
by bulk degradation. This difference allows the ma-
terial to retain its mechanical characteristics and
provide prolonged separation of adhering tis-
sues.34-36 Furthermore, degradation of PTMC in-
duces only mild inflammatory reaction, leading
to the hypothesis that intraperitoneal placement
of PTMC film gives a reduction of postoperative
adhesions comparable with or even better than
commercially available materials.34
The results of this experiment indicate PTMC
film (FlexiSurge Adhesion Barrier) does lead to a
significant reduction in the amount of adhesions.
The fact that the PTMC results are comparable to
HA-CMC (Seprafilm), which is also a solid film,
indicates that physical barriers are an effective way
to prevent adhesions. As a more slowly degrading
material, PTMC provides long-term and effective
separation of tissues, because its degradation
happens through surface erosion. This reduction
is significant compared with the control group,
indicating the application of a physical barrier is
beneficial in adhesion prevention.
Surprisingly, the liquid adhesion barrier did not
lead to a reduction in the number of adhesions.
Although human trials are inconclusive,37 icodex-
trin (Adept) does seem to be effective in several
other studies.8,38
Furthermore, there are experimental studies
indicating that icodextrin is also effective in rat
models, showing less adhesion formation
compared with Ringers lactate.13,39 However, in
these studies icodextrin solution was either pro-
vided in higher volumes or in greater concentra-
tions, possibly allowing the liquid to remain
effective for longer periods of time. It is assumed
that the reason for a reduced effectiveness in rats
is the presence of a-amylase in the peritoneal fluid
of rats, leading to a faster resorption of the icodex-
trin fluid, reducing the duration the fluid remains
present in the abdominal cavity.13,40 This could
have resulted in the ineffectiveness of the fluid in
our study.
Another strong aspect of the new PTMC film is
its handling. In contrast with the HA-CMC film,
PTMC is highly flexible with sufficient tensile
strength, allowing for easy positioning and reposi-
tioning within the first few minutes after implan-
tation,18,34 whereas the HA-CMC film is reported
to be brittle, sticky, and difficult to apply, limiting
its use in surgical practice.15,41 Furthermore, the
HA-CMC barrier was completely resorbed in allanimals after the 14 days follow-up, whereas the
PTMC film kept its structural integrity at least until
day 14. Although peritoneal wound healing is
completed after 7–10 days, the HA-CMC material
loses its structural integrity within the first 24 hours
by turning into a hydrophilic gel.14,42,43 Because
the PTMC material degrades through surface
erosion, it may provide adequate tissue separation
for a longer period of time.16,34
Because damage to the mesothelial lining and
the subsequent fibrotic response are considered to
be key components in adhesion formation, the
main focus of adhesion prevention should lie
within the first 7–10 days.14,42 For this reason, we
think a follow-up of 14 days provides adequate in-
formation on the effect of PTMC barrier on adhe-
sion prevention. Beside, after 14 days, the presence
of an intact barrier shows PTMC exceeds the dura-
tion of protection of both HA-CMC and
icodextrin.
Although adhesion formation can have long-
term, detrimental effects on the quality of life of
patients, in some cases adhesion formation is
necessary, for example, for in anastomotic healing.
It has been shown that certain antiadhesive prod-
ucts may predispose to peritonitis and anastomotic
dehiscence.11,44 To address this issue, we placed
PTMC film in both the presence of a colonic anas-
tomosis as well as in a model for controlled infec-
tion. In both models, the presence of the PTMC
film did not cause any increase in anastomotic
leakage rate, nor did it aggravate the induced
infection. We did not compare PTMC with the
other products, because they are already available
on the market and therefore have been tested for
safety. Furthermore, because there were no differ-
ences between PTMC and control, there are no
risks involved in using PTMC in an infected
abdomen in a rat model.
Unfortunately, at the time of writing, PTMC film
required suture fixation to maintain adequate
positioning throughout the follow-up. Although
the PTMC reduced the number of adhesions to
the ischemic buttons significantly, unprotected
sutures fixing the film seemed to induce adhesion
formation at this site. The need for sutured
fixations was one of the limitations for practical
PTMC film application. Before the film can be
tested in a clinical setting, the fixation strength of
an attached, tacky copolymer layer should be
sufficient to provide sutureless fixation.
Another limitation of this study is a possible lack
of power to detect any significant differences in
number of adhesions to the cecal abrasion.
Although the results of PTMC films are excellent
Surgery
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effectiveness in preventing adhesions in other
locations in the abdomen could not be shown in
this model. However, there still seems to be a small,
albeit not significant, reduction in the cecal
adhesion formation, which could have clinical
implications in larger groups.
In conclusion, a new PTMC film with a tacky
PTMC-PEG layer is effective in reducing postoper-
ative adhesions to the abdominal wall in a rat
ischemic button model. Furthermore, the use of
this film does not compromise anastomotic heal-
ing or peritonitis. The proven efficacy and safety in
this preclinical study, along with the easy handling
of the PTMC film make it a promising new
prevention tool in postoperative adhesions.
Further research is necessary to elucidate whether
these results are also valid in humans.
Funding for acquisition of materials and animals was
kindly provided by Medisse BV, Ede, The Netherlands.
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